NCT05017025 2026-05-20Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung CancerM.D. Anderson Cancer CenterPhase 1/2 Active not recruiting32 enrolled